Page 36 - Glucose Monitoring Devices
P. 36
References 31
[130] Price D, Walker T. The rationale for continuous glucose monitoring-based diabetes
treatment decisions and non-adjunctive continuous glucose monitoring use. European
Endocrinology 2016;12:24. https://doi.org/10.17925/ee.2016.12.01.24.
[131] Dov c K, Bratina N, Battelino T. A new horizon for glucose monitoring. Hormone
Research in Paediatrics 2015;83:149e56. https://doi.org/10.1159/000368924.
[132] Charleer S, Mathieu C, Nobels F, De Block C, Radermecker R, Hermans M, et al.
Effect of continuous glucose monitoring on glycemic control, acute admissions, and
quality of life: a real-world study. Journal of Clinical Endocrinology and Metabolism
2018;103:1224e32. https://doi.org/10.1210/jc.2017-02498.
[133] Rodbard D. Continuous glucose monitoring: a review of recent studies demonstrating
improved glycemic outcomes. Diabetes Technology and Therapeutics 2017;19.
https://doi.org/10.1089/dia.2017.0035. S-25-S-37.
[134] Battelino T. Continuous glucose monitoring efficacy in routine use. Journal of Clinical
Endocrinology and Metabolism 2018;103:2414e6. https://doi.org/10.1210/jc.2018-
00275.
[135] Aleppo G, Laffel L, Ahmann A, Hirsch I, Kruger D, Peters A, et al. A practical
approach to using trend arrows on the dexcom G5 CGM system for the management
of adults with diabetes. Journal of the Endocrine Society 2017;1:1445e60. https://
doi.org/10.1210/js.2017-00388.